Topic

Webcasts

Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET

The Importance of IRT in the Decentralized Clinical Trial Landscape

Executive Director and Professor, Tufts University School of Medicine

SVP, Head of Clinical Development Operations, Bayer

VP, Head of GCTO Regions and Head Quarters Functions at Merck & Co

Articles

Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors. 

Redefining CRO Sourcing Model Terminology to Optimize Outsourcing Strategies

Danielle Mitchell, Founder of Black Women in Clinical Research, discusses how her foundation bridges the gap between minority professionals and clinical trials.

Breaking the Minorities Gap in Clinical Operations

Chair of Frier Levitt’s White Collar Defense and Government Investigations practice

Aggressive focus by DOJ has put increased burden on stakeholders to understand their obligations and exposure.

Are You a Victim of Clinical Trial Fraud?  If So, What Are Your Rights and Obligations?

Director of Product Marketing, LifeSphere Clinical at 

Work across varying therapeutic areas and new technology among reasons why CROs are qualified to advance model.

How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange Mechanism

Vice President - Compliance and Quality, Advanced Clinical

Minimizing impacts through focus on employee wellness.

Compliance Amid the ‘Great Resignation’ 

26 interviews conducted by Tufts CSDD found that gender-based microaggressions can negatively impact collaboration and affect retention of women employees.

The Impact of Gender Microaggressions on Team Performance in Drug Development

Survey taken by CROs and pharma/biotech companies seeks answers in maximizing partnership.

What Stands in the Way of an Efficient CRO-Pharma Collaboration?

Legal Executive, Clinical Research Malaysia

Legal Assistant, Clinical Research Malaysia

How Clinical Research Malaysia sped up CTA turnaround using a web-based system.

Managing Clinical Trial Agreements 

In this Q&A, ACT catches up with Brian Ford, director, functional service partnership solutions, PPD Clinical Research Services, Thermo Fisher Scientific, to answer some frequently asked questions about how ILs contribute to the successful use of FSP models.

CRO/Sponsor